1. | Circular issued regarding certain instructions on sale of Oxytocin |
2. | Circular issued regarding certain instructions on sale of Oxytocin |
3. | Classification of Medical Devices - List of Medical Devices, IVDs along with their risk class under provisions of sub-rule 1 Rule 4 of the Medical Devices Rules, 2017 |
4. | Classification of Medical Devices - List of Medical Devices, IVDs along with their risk class under provisions of sub-rule 1 Rule 4 of the Medical Devices Rules, 2017 |
5. | Medical Devices Rules 2017 |
6. | Medical Devices Rules 2017 |
7. | List of Notified Bodies registered with CDSCO under Medical Devices Rules. |
8. | List of Notified Bodies registered with CDSCO under Medical Devices Rules. |
9. | Grouping guidelines for Medical Devices applications |
10. | Grouping guidelines for Medical Devices applications |
11. | FAQs on Medical Devices Rules |
12. | FAQs on Medical Devices Rules |
13. | Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs |
14. | Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs |
15. | Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A |
16. | Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A |
17. | Fixed Dose Combinations FDCs approved by DCG (I) since 1961 to 31st December 2019 |
18. | Fixed Dose Combinations FDCs approved by DCG (I) since 1961 to 31st December 2019 |
19. | GUIDELINES FOR TAKING ACTION ON SAMPLES OF DRUGS DECLARED SPURIOUS OR NOT OF STANDARD QUALITY |
20. | GUIDELINES FOR TAKING ACTION ON SAMPLES OF DRUGS DECLARED SPURIOUS OR NOT OF STANDARD QUALITY |
21. | Standards for Blood Banks and Blood Transfusion Services |
22. | Standards for Blood Banks and Blood Transfusion Services |
23. | Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers |
24. | Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers |
25. | Guidance Document and Steps to be followed by the manufcaturers/importers for registration of Non-notified Medical Devices. |
26. | Instructions issued to Drugs Inspectors regarding regulation of sale and distribution of N95 Masks, PPE, Hand Sanitizers and related medicines. |
27. | Cosmetics Rules 2020 |
28. | Guidance Document and Steps to be followed by the manufcaturers/importers for registration of Non-notified Medical Devices. |
29. | Instructions issued to Drugs Inspectors regarding regulation of sale and distribution of N95 Masks, PPE, Hand Sanitizers and related medicines. |
30. | Cosmetics Rules 2020 |
31. | Circular regarding procedure to be adopted in the investigation and recall of the drugs declared as NSQ or Spurious |
32. | Circular regarding procedure to be adopted in the investigation and recall of the drugs declared as NSQ or Spurious |
33. | Circular regarding Rule 84AB for uploading data of drug manufacturing facilities and approved drug formulations on SUGAM portal |
34. | Circular regarding Rule 84AB for uploading data of drug manufacturing facilities and approved drug formulations on SUGAM portal |
35. | Circular of DCGI regarding modalities of Joint Inspection for Grant of Manufacturing Licence |
36. | Circular of DCGI regarding modalities of Joint Inspection for Grant of Manufacturing Licence |
37. | GSR 1337E dated 27-10-2017 regarding retention of licences, omission of renewal |
38. | GSR 1337E dated 27-10-2017 regarding retention of licences, omission of renewal |
39. | Consequential Amendments to GSR 1337E Gazette Notification |
40. | Consequential Amendments to GSR 1337E Gazette Notification |
41. | New Drugs and Clinical Trial Rules 2019 |
42. | New Drugs and Clinical Trial Rules 2019 |
43. | FAQs on New Drugs and Clinical Trial Rules 2019 |
44. | FAQs on New Drugs and Clinical Trial Rules 2019 |
Designed, Developed and Hosted by National Informatics Centre, Hyderabad.
Content owned, maintained and updated by Department of Drugs Control Administration, Government of Telangana